← SynDRA
BRD-K83354763
SynDRA canonical compound SYN0062719 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | RELA |
|---|
| Mechanism of action | NFkB pathway inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- NFKB-activation-inhibitor-II
- 4-Methyl-N1-(3-phenylpropyl)benzene-1,2-diamine
- RefChem:525503
- JSH 23
- 4-Methyl-1-N-(3-phenylpropyl)benzene-1,2-diamine
- MFCD09753595
- NF-kappaB activation inhibitor II
- 4-methyl-n1-(3-phenylpropyl)-1,2-benzenediamine
- 4-Methyl-N1-(3-phenylpropyl)-1,2-phenylenediamine
- 4-Methyl-N~1~-(3-phenylpropyl)benzene-1,2-diamine
- orb1307077
- SCHEMBL1424836
- SCHEMBL29351335
- CHEBI:94768
- JSH-23?
- CHEBI:131326
- GLXC-04503
- HMS3653C16
- HMS3886H13
- EX-A2083
- FD5025
- s7351
- AKOS005931310
- CCG-266875
- AC-33089
- BS-18051
- DA-33455
- HY-13982
- SY056416
- M2734
- SW218183-2
- T1930
- 4-methyl-n1-(3-phenyl-propyl)-benzene-1,2-diamine
- 4-methyl-N(1)-(3-phenylpropyl)benzene-1,2-diamine
- BRD-K83354763-001-02-9
- BRD-K83354763-001-03-7
- BRD-K83354763-001-06-0
- 4-Methyl-N¹-(3-phenylpropyl)benzene-1,2-diamine
Look up BRD-K83354763 in the interactive SynDRA portal →